USFDA Grants Orphan Drug Status to Shilpa-mAbTree Biologic for Rare Blood Cancers
New Delhi: Shilpa Biologicals Pvt Ltd, part of the Shilpa Medicare Group, along with Switzerland-based mAbTree Biologics AG, has received Orphan Drug Designation (ODD) from the US Food and Drug…